Stock DGXQUEST DIAGNOSTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Quest Diagnostics Incorporated Share Price

Equities

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 01:30:02 12/07/2025 am IST 		5-day change 1st Jan Change
168.09 USD -1.96% Intraday chart for Quest Diagnostics Incorporated -4.99% +11.42%
08/07 Leerink Partners Adjusts PT on Quest Diagnostics to $192 From $189, Maintains Outperform Rating MT
30/06 Quest Diagnostics Incorporated(NYSE:DGX) dropped from Russell 1000 Dynamic Index CI

Valuation: Quest Diagnostics Incorporated

Capitalization 1.88TCr 1.61TCr 1.49TCr 1.39TCr 2.57TCr 1,61000Cr 2.85TCr 18TCr 6.83TCr 75TCr 7.04TCr 6.89TCr 2,76600Cr P/E ratio 2025 *
19.7x
P/E ratio 2026 * 17.9x
Enterprise value 2.43TCr 2.08TCr 1.93TCr 1.8TCr 3.32TCr 2,08200Cr 3.69TCr 23TCr 8.84TCr 97TCr 9.1TCr 8.92TCr 3,57800Cr EV / Sales 2025 *
2.25x
EV / Sales 2026 * 2.13x
Free-Float
67.83%
Yield 2025 *
1.8%
Yield 2026 * 1.86%
More valuation ratios * Estimated data

Chart: Quest Diagnostics Incorporated

Dynamic Chart

Latest news: Quest Diagnostics Incorporated

Leerink Partners Adjusts PT on Quest Diagnostics to $192 From $189, Maintains Outperform Rating 08/07 MT
Quest Diagnostics Incorporated(NYSE:DGX) dropped from Russell 1000 Dynamic Index 30/06 CI
Quest Diagnostics to Develop Multi-Cancer Stratification Blood Test Based on Md Anderson Technology 10/06 CI
PreciseDx, Inc. announced that it has received $11.230074 million in funding from Eventide Asset Management, LLC, Merck Global Health Innovation Fund, LLC, Philips Venture Capital Fund BV, Labcorp Holdings Inc., Quest Diagnostics Incorporated, GenHenn Capital 06/06 CI
Quest Diagnostics Incorporated Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10:00 AM 03/06
PreciseDx, Inc. announced that it expects to receive $38.349944 million in funding from Eventide Asset Management, LLC, Merck Global Health Innovation Fund, LLC, Philips Venture Capital Fund BV, Labcorp Holdings Inc., Quest Diagnostics Incorporated, GenHenn Capital 28/05 CI
Quest Diagnostics Insider Sold Shares Worth $306,800, According to a Recent SEC Filing 15/05 MT
Qiagen Q1 Adjusted Earnings, Revenue Rise; New $500 Million Stock Buyback Planned 08/05 MT
JPMorgan Adjusts Price Target on Quest Diagnostics to $190 From $180, Maintains Neutral Rating 06/05 MT
Privia Health Group, Inc. : Beginning of a new cycle 02/05Our Logo
Labcorp beats quarterly profit estimate on diagnostic test demand 29/04 RE
Piper Sandler Adjusts Price Target on Quest Diagnostics to $200 From $180, Maintains Neutral Rating 28/04 MT
Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010. 24/04 CI
More news

Last Transcript: Quest Diagnostics Incorporated

Logo Quest Diagnostics Incorporated
Quest Diagnostics Incorporated Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10:00 AM
03/06
More transcripts

Analysts' recommendations: Quest Diagnostics Incorporated

Leerink Partners Adjusts PT on Quest Diagnostics to $192 From $189, Maintains Outperform Rating 08/07 MT
JPMorgan Adjusts Price Target on Quest Diagnostics to $190 From $180, Maintains Neutral Rating 06/05 MT
Piper Sandler Adjusts Price Target on Quest Diagnostics to $200 From $180, Maintains Neutral Rating 28/04 MT
Morgan Stanley Adjusts Quest Diagnostics Price Target to $182 From $172, Maintains Overweight Rating 23/04 MT
Baird Adjusts Quest Diagnostics Price Target to $194 From $191, Maintains Outperform Rating 23/04 MT
More recommendations

Press Releases: Quest Diagnostics Incorporated

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease 09/07 PR
Quest Diagnostics Releases 2024 Corporate Responsibility Report 25/06 PR
Quest Diagnostics Incorporated : 2024 Report 24/06 PU
Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025 23/06 PR
Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology 10/06 PR
More press releases

News in other languages: Quest Diagnostics Incorporated

RECOMENDACIONES DE LOS ANALISTAS UK/EE.UU: Tesla, Constellations Brands, Old Dominion, Stellantis, Lloyds... 05/24/05
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK: Ecolab, Texas Instruments, Cisco, Britvic, Shopify... 16/24/16
RECOMENDACIONES DE LOS ANALISTAS EE.UU.: Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever.... 21/24/21
RECOMENDACIONES DE LOS ANALISTAS EE.UU.: Caterpillar, Eli Lilly, Intel, Caterpillar, Shopify, Snap, Meta, T-Mobile... 07/24/07
Recomendaciones de los analistas EE.UU./UK: Burberry Group, Blackrock, Deliveroo, Unitedhealth, JPMorgan Chase, Qualcomm, Sage... 15/24/15
More news

Quotes and Performance

1 day-1.96%
1 week-4.99%
Current month-6.42%
1 month-5.27%
3 months+2.59%
6 months+10.74%
Current year+11.42%
More quotes

Course Extremes

1 week 167.14
Extreme 167.14
 176.11
1 month 167.14
Extreme 167.14
 182.38
Current year 148.7
Extreme 148.7
 182.38
1 year 137.71
Extreme 137.71
 182.38
3 years 119.59
Extreme 119.59
 182.38
5 years 104.1
Extreme 104.1
 182.38
10 years 59.66
Extreme 59.655
 182.38
More quotes

Managers and Directors: Quest Diagnostics Incorporated

Manager TitleAgeSince
James Davis CEO
 Chief Executive Officer 62 03/02/2022
Sam Samad DFI
 Director of Finance/CFO 55 11/07/2022
Kristin Wallace CMP
 Compliance Officer - 01/08/2022
Director TitleAgeSince
Gary Pfeiffer BRD
 Director/Board Member 75 01/12/2004
Timothy Ring BRD
 Director/Board Member 67 07/12/2011
James Davis CHM
 Chairman 62 01/04/2023
More insiders

ETFs: Quest Diagnostics Incorporated

Name Weight AuM 1st Jan change
AGF U.S. MARKET NEUTRAL ANTI-BETA FUND - USD ETF AGF U.S. Market Neutral Anti-Beta Fund - USD
14.84% 378 M€ -7.52% -
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED ETF First Trust AlphaDEX U.S. Health Care Sector Index ETF - CAD Hedged
2.17% 3 M€ -.--% -
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD ETF First Trust AlphaDEX U.S. Health Care Sector Index ETF - CAD
2.05% 6 M€ 0.00% -
More ETFs: Quest Diagnostics Incorporated

Other Healthcare Facilities & Services

Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi.($)
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-1.96%-4.99%+19.68%+23.83% 1.91TCr
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
-0.59%-0.14%+19.25%+117.89% 9.1TCr
CVS HEALTH CORPORATION Stock CVS Health Corporation
-1.28%-3.93%+12.60%-31.22% 8.3TCr
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.66%-1.06%+44.57%+45.07% 2.78TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
-0.75%-1.49%-6.36%+38.74% 2.47TCr
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-1.58%-4.69%+24.58%+2.33% 2.12TCr
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+1.20%+2.48%+34.47%+218.73% 1.61TCr
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.45%-3.38%+27.72%-2.82% 1.61TCr
MAX HEALTHCARE INSTITUTE LIMITED Stock Max Healthcare Institute Limited
-2.56%-6.29%+34.53%+235.23% 1.42TCr
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
-1.51%-4.67%+16.23%+14.24% 1.34TCr
Average -1.11%-2.37%+22.73%+66.20% 3.27TCr
Weighted average by Cap. -1.01%-1.90%+19.86%+54.67%
See all sector performances

Financials

2025 *2026 *
Net sales 1.08TCr 923.57Cr 859.37Cr 800.44Cr 1.48TCr 93TCr 1.64TCr 10TCr 3.93TCr 43TCr 4.05TCr 3.96TCr 1,59100Cr 1.12TCr 961.19Cr 894.37Cr 833.04Cr 1.54TCr 96TCr 1.71TCr 11TCr 4.09TCr 45TCr 4.21TCr 4.13TCr 1,65600Cr
Net income 97Cr 83Cr 78Cr 72Cr 133.25Cr 8.35TCr 147.99Cr 929.46Cr 354.51Cr 3.91TCr 365.1Cr 357.55Cr 14TCr 107Cr 92Cr 85Cr 79Cr 146.46Cr 9.18TCr 162.66Cr 1.02TCr 389.65Cr 4.3TCr 401.29Cr 393Cr 16TCr
Net Debt 550.9Cr 471.36Cr 438.59Cr 408.52Cr 754.07Cr 47TCr 837.49Cr 5.26TCr 2.01TCr 22TCr 2.07TCr 2.02TCr 81TCr 512.03Cr 438.11Cr 407.65Cr 379.7Cr 700.87Cr 44TCr 778.4Cr 4.89TCr 1.86TCr 21TCr 1.92TCr 1.88TCr 75TCr
More financial data * Estimated data

Company Profile

Logo Quest Diagnostics Incorporated
Quest Diagnostics Incorporated is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (3%).
Employees
50,500
Sector
Healthcare Facilities & Services
Calendar
22/07 - Q2 2025 Earnings Release
More about the company

Quotes

Date Price Change Volume
11/25/11 168.09 $ -1.96% 13,24,953
10/25/10 171.45 $ -1.25% 9,14,082
09/25/09 173.62 $ +0.65% 8,71,070
08/25/08 172.50 $ -0.84% 10,80,477
07/25/07 173.97 $ -1.67% 8,39,409

Delayed Quote Nyse, July 12, 2025 at 01:30 am IST

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
168.09USD
Average target price
184.10USD
Spread / Average Target
+9.52%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. DGX Stock

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition